Ophthalmology Times: March 2022

Study focuses on potential biologic to treat allergic eye disease

March 18, 2022

A team of investigators has found that nomacopan, a recombinant biologic derived from blood-feeding ticks, may be an option for the treatment of allergic eye disease due to its ability to down-regulate the LTB4/C5 pathways in experimental allergy conjunctivitis.

Intensive multimodal therapy is effective for orbital retinoblastoma

March 17, 2022

Investigators observe survival rate with orbital retinoblastoma improves substantially due to a combination approach that includes intensive sequential treatment comprised of chemotherapy, enucleation, and external beam radiation therapy.